Tag: UGANDA

Zimbabwe Among 14 African Nations Facing Alarming Rise in Drug-Resistant Infections

Michael Gwarisa

By Staff Reporter  Results from a newly published study highlight the growing spread of drug resistance across 14 African countries, underscoring the urgent need to strengthen laboratory testing, data systems, and health planning to tackle hard-to-treat infections. The study, known as the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP), is the largest of its kind ever conducted in Africa. It was led by a coalition including the Africa Centres for Disease Control and Prevention (Africa CDC), the African Society for Laboratory Medicine (ASLM), One Health Trust, and other regional partners.…

Read More

Gilead’s Secrecy Over HIV Prevention Shot Sparks Global Outrage

Michael Gwarisa

By Staff Reporter  Gilead Sciences has come under fire after announcing a secretive deal to supply its long-acting injectable HIV prevention drug, lenacapavir (LEN-LA), to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The agreement—shrouded in indefinite price secrecy—has been widely condemned by civil society organisations, health advocates, and global health experts who warn it undermines transparency, accountability, and equitable access. The Global Fund, financed by public money, has invited nine African countries—South Africa, Eswatini, Lesotho, Mozambique, Kenya, Uganda, Zambia, Zimbabwe, and Nigeria—to participate in the agreement. However, the…

Read More

Zimbabwe Joins Rollout of First-Ever Oral Treatment for Deadly Sleeping Sickness

Michael Gwarisa

By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic regions like Zimbabwe, where tsetse fly infestations remain a concern. The new drug, Fexinidazole Winthrop, is now being offered free of charge in specialized treatment centres in Zimbabwe, Malawi, Ethiopia, Tanzania, and Zambia. Its approval…

Read More

Rampant Sexual Networks Hinder Mpox Response in Africa

Michael Gwarisa

By Michael Gwarisa Efforts to curb the spread of Mpox among African Union member states remain a challenge due to widespread and interconnected sexual networks, HealthTimes has learned. Uganda currently leads in new Mpox cases, accounting for 50% of all recorded infections in Africa over the past six weeks. The majority of cases in Uganda stem from the Clade 1B strain, which is sexually transmitted. Uganda, Burundi, and the Democratic Republic of Congo (DRC) have collectively recorded 94% of confirmed cases since the beginning of the year. Speaking during the…

Read More

In Uganda, Fake Doctors Cause Serious Damage

Healthtimes

By Apophia Agiresaasi, GPJ Uganda KAMPALA, UGANDA — Days after an emergency cesarean section at a private clinic, Barbara Kwarikunda experienced excruciating pain. “I couldn’t eat,” she says. “I would feel pain whenever someone touched me. My stomach was swollen. I felt like something was bursting in my uterus.” Visits to the clinic didn’t help. An examination at a public hospital revealed that the people who operated on her left cotton and gauze in her uterus. They also slightly severed her intestine, which caused internal leaking. She required another surgery…

Read More

US Claims Ebola Funding Was Restored. Ugandan Health Workers Still Haven’t Seen the Money

Healthtimes

By Nakisanze Segawa, GPJ Uganda KAMPALA, UGANDA — On Jan. 20, US President Donald Trump abruptly cut funding for the surveillance of and response to an outbreak of the Sudan Ebola virus here. Elon Musk, Trump’s unelected right hand, said in a cabinet meeting on Feb. 26 that the Ebola-response funding was “accidentally” cut but restored immediately. Health workers in Uganda, though, say they’ve seen no sign that the funding has been restored. The United States Agency for International Development administered most of the United States’ foreign aid — until…

Read More

Ebola Breaks Out in Uganda as US Halts Foreign Aid

Healthtimes

By Nakisanze Segawa, GPJ Uganda KAMPALA, UGANDA — One nurse died from the Sudan Ebola virus in Uganda on Jan. 29. Two more cases were confirmed days later — and hundreds of people were direct contacts. The virus spreads fast, and it’s deadly: The Sudan strain’s fatality rate ranged from 40% to 100% in past outbreaks, and there are no approved vaccines. Now, the United States Agency for International Development, a key partner in treating Ebola and slowing its spread, has stopped all funding for global health and all of…

Read More

Breakthrough Study Finds African Children with Severe Malaria Showing Partial Resistance to Leading Malaria Drug

Michael Gwarisa

By Staff Reporter A new study from Uganda provides the first evidence to date that resistance to a lifesaving malaria drug may be emerging in the group of patients that accounts for most of the world’s malaria deaths: young African children suffering from serious infections. The study, presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene and published in the Journal of the American Medical Association (JAMA), documented partial resistance to the malaria drug artemisinin in 11 of 100 children, ages 6 months to…

Read More

Zimbabwe Among 17 African Nations to Receive WHO and Africa CDC Support for Targeted Mpox Vaccine Rollout

Michael Gwarisa

By Michael Gwarisa Zimbabwe has been selected as one of 17 African countries to receive targeted support for mpox vaccine development, a major initiative spearheaded by the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC). The initiative aims to bolster vaccine preparedness and deployment efforts across the continent, with a focus on effectively reaching populations most at risk of mpox. Other countries benefiting from this support include Burundi, Cameroon, Central African Republic, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Ghana, Guinea, Liberia,…

Read More

WHO-Afro Calls For Collaborative Cross-Border Surveillance for Mpox In Africa

Michael Gwarisa

By Michael Gwarisa While Mpox cases have been on a downward trend in most World Health Organisation (WHO) regions, the same cannot be said for Africa as cases have been increasing every month since the beginning of 2024. With over 99,000 laboratory-confirmed cases, and 208 deaths having been confirmed globally since January 2024, the total number of cases reported in 12 African countries as of August 18, 2024, according to the WHO Afro Region is 4,562 and 35 lab-confirmed deaths. WHO has since declared Mpox a Public Health Emergency of…

Read More